Description of the SAGjE Cohort: A large European study of mortality and cancer incidence risks after childhood treatment with recombinant growth hormone

AJ Swerdlow; R Cooke; K Albertsson-Wikland; B Borgstrom; GE Butler; S Cianfarani; P Clayton; J Coste; A Deodati; E Ecosse; R Gausche; C Giacomozzi; W Kiess; Anita Hokken - Koelega; CE Kuehni; F Landier; M Maes; PE Mullis; R Pfaffle; L Savendahl; G Sommer; M Thomas; S Tollerfield; null Zandwijken; JC Carel

Description of the SAGjE Cohort: A large European study of mortality and cancer incidence risks after childhood treatment with recombinant growth hormone

AJ Swerdlow, R Cooke, K Albertsson-Wikland, B Borgstrom, GE Butler, S Cianfarani, P Clayton, J Coste, A Deodati, E Ecosse, R Gausche, C Giacomozzi, W Kiess, Anita Hokken - Koelega, CE Kuehni, F Landier, M Maes, PE Mullis, R Pfaffle, L SavendahlG Sommer, M Thomas, S Tollerfield, Zandwijken, JC Carel

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	172-183
Number of pages	12
Journal	Hormone Research in Paediatrics
Volume	84
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Swerdlow, AJ., Cooke, R., Albertsson-Wikland, K., Borgstrom, B., Butler, GE., Cianfarani, S., Clayton, P., Coste, J., Deodati, A., Ecosse, E., Gausche, R., Giacomozzi, C., Kiess, W., Hokken - Koelega, A., Kuehni, CE., Landier, F., Maes, M., Mullis, PE., Pfaffle, R., ... Carel, JC. (2015). Description of the SAGjE Cohort: A large European study of mortality and cancer incidence risks after childhood treatment with recombinant growth hormone. Hormone Research in Paediatrics, 84, 172-183.

@article{12ebd1030f6c406c8068ec28093a2435,

title = "Description of the SAGjE Cohort: A large European study of mortality and cancer incidence risks after childhood treatment with recombinant growth hormone",

author = "AJ Swerdlow and R Cooke and K Albertsson-Wikland and B Borgstrom and GE Butler and S Cianfarani and P Clayton and J Coste and A Deodati and E Ecosse and R Gausche and C Giacomozzi and W Kiess and {Hokken - Koelega}, Anita and CE Kuehni and F Landier and M Maes and PE Mullis and R Pfaffle and L Savendahl and G Sommer and M Thomas and S Tollerfield and Zandwijken and JC Carel",

year = "2015",

language = "Undefined/Unknown",

volume = "84",

pages = "172--183",

journal = "Hormone Research in Paediatrics",

issn = "1663-2818",

publisher = "Karger",

}

Swerdlow, AJ, Cooke, R, Albertsson-Wikland, K, Borgstrom, B, Butler, GE, Cianfarani, S, Clayton, P, Coste, J, Deodati, A, Ecosse, E, Gausche, R, Giacomozzi, C, Kiess, W, Hokken - Koelega, A, Kuehni, CE, Landier, F, Maes, M, Mullis, PE, Pfaffle, R, Savendahl, L, Sommer, G, Thomas, M, Tollerfield, S, Zandwijken & Carel, JC 2015, 'Description of the SAGjE Cohort: A large European study of mortality and cancer incidence risks after childhood treatment with recombinant growth hormone', Hormone Research in Paediatrics, vol. 84, pp. 172-183.

TY - JOUR

T1 - Description of the SAGjE Cohort: A large European study of mortality and cancer incidence risks after childhood treatment with recombinant growth hormone

AU - Swerdlow, AJ

AU - Cooke, R

AU - Albertsson-Wikland, K

AU - Borgstrom, B

AU - Butler, GE

AU - Cianfarani, S

AU - Clayton, P

AU - Coste, J

AU - Deodati, A

AU - Ecosse, E

AU - Gausche, R

AU - Giacomozzi, C

AU - Kiess, W

AU - Hokken - Koelega, Anita

AU - Kuehni, CE

AU - Landier, F

AU - Maes, M

AU - Mullis, PE

AU - Pfaffle, R

AU - Savendahl, L

AU - Sommer, G

AU - Thomas, M

AU - Tollerfield, S

AU - Zandwijken, null

AU - Carel, JC

PY - 2015

Y1 - 2015

M3 - Article

SN - 1663-2818

VL - 84

SP - 172

EP - 183

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

ER -